Phase 4 Migraine Trial, Recruiting NCT04925414 Sponsor: Centre Hospitalier Universitaire de Nice Condition: Migraine
Back to Migraine

Phase 4 Migraine Trial, Recruiting

NCT04925414
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who are covered by French public health insurance
  • People admitted to an emergency department with a headache that appears to be a migraine, based on recognised international diagnostic criteria
  • People who have given written agreement to participate

Who may not be able to join:

  • People who have COPD or any other long-term breathing or respiratory condition
  • Women who are pregnant, breastfeeding, or who could become pregnant and are not using contraception (a pregnancy test will be carried out for women of childbearing age, and results will be shared with a doctor of their choice)
  • People who are under a legal protection order (confirm with trial site)
  • People who have taken triptan medication within the past 2 weeks
  • People who have taken anti-inflammatory pain relief (NSAIDs) within the hour before being examined by the doctor
  • People whose migraine attack has been severely disabling and ongoing for more than 72 hours

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +334.92.03.85.35

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
1 October 2023
Est. completion
1 April 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Pain evaluation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov